Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy

NCT01891123 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer
Breast Cancer
Nasal Cancer

Interventions

DEVICE: PK guided arm
DRUG: PTX 175mg/m2, DOC 75mg/m2

Sponsor

Sun Yat-sen University